share_log

奥泰生物(688606.SH):募投项目结项并将节余募集资金用于永久补充公司流动资金

Aotecarbio (688606.SH): Completion of the fundraising project and use of the remaining funds to permanently supplement the company's working capital.

Gelonghui Finance ·  Jul 19 04:28

On July 19th, Gelunhui announced that Otaibio (688606.SH) held its 3rd Board of Directors and 3rd Supervisory Board 5th meeting on July 19th, 2024. The Proposal on "Partially closing the raised investment projects and using the remaining funds to supplement the permanent working capital" was deliberated and approved. The company agreed to invest the raised funds in the projects "New industrialized technology upgrade project for the annual production of 0.265 billion people's diagnostic reagents" and "IVD R&D Center Construction Project" (referred to as the "raised investment projects") and use the remaining raised funds to supplement the company's permanent working capital.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment